Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
ACS Nano|September 9, 2023
Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell LymphomaMathew R Schnorenberg, Katrina M Hawley, Anika T Thomas-Toth, et al.
Cancer Immunology Research|May 11, 2026
Low-Strength Type I Interferon Signaling Promotes CAR T Cell Treatment EfficacyErting Tang, Yifei Hu, Guoshuai Cao, et al.
Cancer|June 6, 2022
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual diseaseAmi V Desai, Mark A Applebaum, Theodore G Karrison, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Tumor nutrient stress gives rise to a drug tolerant cell state in pancreatic cancerColin Sheehan, Lyndon Hu, Guillaume Cognet, et al.
Leukemia|February 21, 2014
Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemiaC Reynolds, J E Roderick, J L LaBelle, et al.
The New England Journal of Medicine|August 30, 2023
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell DiseaseAkshay Sharma, Jaap-Jan Boelens, Maria Cancio, et al.
Transplantation and Cellular Therapy|March 29, 2026
Gene therapy for sickle cell disease: Practice recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene TherapyAkshay Sharma, Adetola Kassim, Alexis Thompson, et al.
ACS Central Science|September 1, 2021
Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular ImmunityLisa R Volpatti, Rachel P Wallace, Shijie Cao, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunityLisa R Volpatti, Rachel P Wallace, Shijie Cao, et al.
Pageof 9